Strategic Analysis of the World Clinical Development Pipelines in the Pharmaceutical Industry


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This strategic analysis service provides detailed analysis of world clinical development pipelines, focusing on the top ten global pharmaceutical manufacturers. The service in powerpoint format (approximately 161 slides) focuses not just only on overall market revenues and competitor analysis but also on strategies for achieving success in this established market and the overall costs of putting a drug through the clinical development process.

Table of Contents

Strategic Analysis of the World Clinical Development Pipelines in the Pharmaceutical Industry, Strategic Analysis of World Clinical Development Pipelines in the Pharmaceutical IndustryOverviewOverviewResearch Scope & MethodologyResearch Scope & MethodologyIntroduction & BackgroundIntroduction & BackgroundGlossaryAbbreviationsPharmaceutical Industry DynamicsPharmaceutical Market DynamicsKey Market TrendsMajor Challenges for the Pharmaceutical IndustryMarket DriversMarket RestraintsOverall State of the MarketForecast AssumptionsMarket Engineering MeasurementsTotal Market Revenue ForecastMarket AnalysisTop Ten Pharmaceutical Companies by RevenueMarket Share AnalysisClinical Development Cost DynamicsClinical Development Cost DynamicsPhases of the Clinical Trials ProcessTesting Procedures Used in Clinical TrialsAssumptions in Estimating Cost of Clinical TrialsChanges in Clinical Trials (1980-2003)Mean Clinical Trial CostsClinical Trial Phase LengthClinical Trial Costs by Disease IndicationClinical Trials in North America Compared to EuropeClinical Trials in Europe: East Versus WestSummary of TrendsFuture Trends in Clinical TrialsResearch Trends & Pipelines of Top Ten Pharmaceutical CompaniesResearch Trends & Pipelines of Top Ten Pharmaceutical CompaniesAssumptions in Pipeline AnalysisOverall Industry Research TrendsPipeline Analysis - Pfizer IncPipeline Analysis - Johnson & Johnson IncPipeline Analysis - GlaxoSmithKline PlcPipeline Analysis - Sanofi-Aventis GroupPipeline Analysis - Novartis AGPipeline Analysis - F. Hoffman-La Roche LtdPipeline Analysis - Merck & Co. IncPipeline Analysis - Bristol-Myers Squibb CompanyPipeline Analysis - Abbott LaboratoriesPipeline Analysis - AstraZeneca PlcStrategic Analysis & RecommendationsStrategic Analysis & RecommendationsMajor Challenges & Strategic ProposalsResearch Priority ForecastStrategic AnticipationMarket Maturation ProcessCompetitive FrameworkPotential ThreatsMeeting the ChallengeFrost & Sullivan AwardsFrost & Sullivan AwardsGrowth Strategy Leadership AwardMarket Leadership AwardProduct Differentiation Innovation AwardWorld Clinical Approvals (2000-2004)World Clinical Approvals (2000-2004)New Drugs Approved by the FDA (2000-2004)New Drugs Approved by the EMEA (2000-2004)Decision Support DatabasesDecision Support DatabasesNumber of Biotechnology Companies - Western Europe and North America (1999-2006)Biotechnology European Patents Filed (1996-2000)Governmental Research and Development Investment in Biotechnology (1999-2006)Pharmaceutical Research and Development Expenditure (1999-2006)Frost & SullivanFrost & SullivanHealthcare TeamOur Capabilities

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.